Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.
Latest News
Dermatology
Blueberry Therapeutics are committed to the development of innovative new therapies for the treatment of common dermatological disorders.
Onychomycosis
(Fungal Nail)
Tinea pedis
(Athlete’s foot)
Acne
.
Nanomedicine
Blueberry Therapeutics use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
News
The Blueberry Team complete 546 km challenge to raise money for In2Science!
From the 19-25th April, Blueberry employees took on a challenge to collectively reach a target distance of 200 km [...]
Blueberry Therapeutics announces extension of its Series B round with investment from Medical Incubator Japan and US Dermatology Syndicate
Blueberry Therapeutics Limited would like to announce that it has completed a £3.6m extension to the previously successful Series B [...]
A Blueberry case study
In this video, Blueberry Therapeutics CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.
Blueberry Therapeutics Ltd Blueberry Therapeutics, Mereside, Alderley Park, Nether Alderley,
Macclesfield, Cheshire, SK10 4TG.